Claudia ZylberbergCEO at Akron Biotech
Claudia Zylberberg, Ph.D. is a leader in regenerative medicine. She is the founder and CEO of Akron Biotechnology, a manufacturer of cGMP-grade ancillary materials for the tissue, cell and gene therapy industry. She also co-founded AssureImmune, an adult stem cell bank. Dr. Zylberberg holds numerous patents and has developed several patent-pending platform technologies in cryopreservation, novel formulations and others. She has authored and co-authored several peer-reviewed publications and has received grants from the NIH and Department of Defense, among others. In her early years, Dr. Zylberberg worked at Nabi Biopharmaceuticals, specializing in human plasma-derived products. Her experience in product development and protein manufacturing has been instrumental for the development of key materials to accelerate the regen med industry. In addition, she co-founded the Standards Coordinating Body (SCB) and is a board member of ISCT, ARM, AABB’s NBF, and the NAS (Regenerative Medicine Forum). Other advisory positions include ISO US TAG, BioFlorida, ISSCR, CBA, and Biomedical Engineering, University of Miami.